Chart Industries, Inc. · NYSE:GTLS

Chart Industries — Investor Presentation (November 2014)

12 slides from Chart Industries's investor presentation, Nov 6, 2014

1. Slide 1: Chart Industries, Inc. Investor Presentation November 2014

   Chart Industries, Inc. Investor Presentation November 2014 © 2014 Chart Industries, Inc. Exhibit 99.1

2. Slide 2: Disclosure: Forward-Looking Statements

   Disclosure © 2014 Chart Industries, Inc. Forward-Looking Statements: This presentation includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The use of words such as “may”, “might”, “should”, “will”, “expect”, “plan”, “anticipate”, “believe

3. Slide 3: Company Overview

   Company Overview Asia 33% U.S. 41% Americas (Non-US) 7% RoW 3% Europe 16% FY 2013 Sales by Segment Energy 53% BioMedical 23% General Industrial 24% FY 2013 Sales by Region FY 2013 Sales by End-User Energy & Chemicals 27% Distribution & Storage 50% BioMedical 23% © 2014 Chart Industries, Inc.  Techn

4. Slide 4: Energy & Chemicals (E&C) Overview

   Energy & Chemicals (E&C) Overview © 2014 Chart Industries, Inc. Middle East 6% Natural Gas Processing 51% Air Separation 9% FY 2013 Sales by Industry Segment / Region Highlights  Technology leader – providing heat exchangers and cold boxes critical to LNG, Olefin petrochemicals, natural gas process

5. Slide 5: Distribution & Storage (D&S) Overview

   Distribution & Storage (D&S) Overview © 2014 Chart Industries, Inc. FY 2013 Sales by Industry Segment / Region Highlights  Balanced customer base – 51% of segment sales derived from products used in energy applications, including LNG  Strategic footprint – manufacturing located near growing end ma

6. Slide 6: BioMedical Overview

   BioMedical Overview © 2014 Chart Industries, Inc. FY 2013 Sales by Industry Segment / Region Highlights  Oxygen therapy market has been impacted by customer consolidation and inventory rationalization in addition to Medicare audits of providers and physicians; anticipate future growth from Asia  L

7. Slide 7: Global Manufacturing

   Global Manufacturing © 2014 Chart Industries, Inc.  Operating leverage provides the flexibility to expand and reduce capacity as needed  Major manufacturing locations include:  North America - Georgia and Minnesota for D&S and BioMedical; also New York for BioMedical; Wisconsin, Louisiana and Okl

8. Slide 8: LNG Value Chain

   LNG Value Chain Uniquely positioned to address the entire LNG Value Chain – liquefaction, distribution, storage and end-use – Chart brings many years of experience in LNG solutions to our customers, facilitating the use of a clean-burning, safe fuel alternative to diesel into the future.  Pre-treat

9. Slide 9: Historical Revenue Trends

   Historical Revenue Trends © 2014 Chart Industries, Inc. 266 269 390 476 593 138 324 319 215199148 205+28% 2013 $1,177 2012 $1,014 2011 $795 2010 $555 2013 +115% $307 2012 $162 2011 $54 2010 $31 BioMed E&C D&S LNG Sales ($MM) Consolidated Sales ($MM) 26% 16% 7% 6% LNG % of Total Revenue CAGR CAGR Cha

10. Slide 10: Historical Orders and Backlog

    Historical Orders and Backlog © 2014 Chart Industries, Inc. 0 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 Q3 14 Q3 10 Q1 14 Q3 12 Q3 13 Q1 13 Q1 12 Q1 11 Q3 11 E&C BioMed D&S 0 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 Q3 10 Q3 14 Q3 11 Q3 12 Q1 14 Q3 13 Q1 12

11. Slide 11: Summary of Investment Highlights

    Summary of Investment Highlights © 2014 Chart Industries, Inc.  Attractive industry with long-term customer relationships  Solid platform with worldwide presence and leading industry positions in all segments  Solid organic earnings should provide substantial free cash flow and good liquidity  P

12. Slide 12: www.chartindustries.com

    © 2014 Chart Industries, Inc. www.chartindustries.com

Chart Industries — Investor Presentation (November 2014) on 6ix